THANK YOU for helping us reaching our fundraising goal!
Our team is committed to raising money to support ALS research.
Please consider joining our team or choose a team member from the list and donate to our cause.
ALS Research at Mayo Clinic
Also known as Lou Gehrig’s disease, amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder characterized by motor neuron degeneration in the motor cortex, brain stem and spinal cord. Progressive weakness of voluntary muscles in ALS patients normally begins around the age of 55, and the resulting paralysis generally leads to respiratory failure and death within 3 - 5 years of disease onset.
At Mayo Clinic Jacksonville, scientists and physicians use a team approach to conduct ALS research with the goal of improving patient care. Their focus is finding new and better ways to predict, prevent, diagnose and optimally treat ALS. Guided by unmet patient needs, researchers work collaboratively in laboratories and on clinical trials and epidemiological studies to turn promising discoveries into effective treatments. Efforts are under way to better understand the pathological mechanisms underlying ALS, identify reliable biomarkers and develop effective therapeutics for patients.
Mayo Clinic is the first and largest integrated, not-for-profit medical group practice in the world. Employees work together to care for patients united by a common philosophy that the needs of the patient come first. The Mayo Clinic Department of Neurology is one of the largest in the world and includes more than 100 subspecialized experts who work together to evaluate and treat patients utilizing the most advanced techniques and technologies. Moreover, a combination of world-renowned experts, unique resources and productive collaborations with clinical colleagues makes the Mayo Clinic Department of Neuroscience a leader in its field.